As of Feb 10
| -0.0008 / -0.42%|
The 1 analysts offering 12-month price forecasts for Immune Therapeutics Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. The median estimate represents a +10,476.41% increase from the last price of 0.19.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.